申请人:OTSUKA PHARMACEUTICAL CO., LTD.
公开号:EP1262181A1
公开(公告)日:2002-12-04
A urease inhibitor and an anti-Helicobacter pylori agent, which contain, as an active ingredient, an isothiazole derivative represented by the general formula (1):
wherein R1 represents a hydrogen atom or an amino group, R2 represents a hydrogen atom, a lower alkyl group, or an acetyl group, and X represents a carbon atom or a nitrogen atom. These drugs are effective to prevent and treat gastrointestinal diseases caused by urease of Helicobacter pylori, such as chronic gastritis and gastroduodenal ulcer.
一种尿素酶抑制剂和一种抗幽门螺旋杆菌剂,其活性成分含有通式(1)代表的异噻唑衍生物:
其中 R1 代表氢原子或氨基,R2 代表氢原子、低级烷基或乙酰基,X 代表碳原子或氮原子。这些药物可有效预防和治疗由幽门螺旋杆菌尿素酶引起的胃肠道疾病,如慢性胃炎和胃十二指肠溃疡。